Rezultati pretraživanja
  1. prije 1 sat

    Check out Investment Fiji's article on"Driving our Exports to New Markets."

  2. prije 7 sati
  3. Interesting...business and property concerns but I wonder how they will address bioequivalence challenges....insights welcome as I'm definitely not well-versed!

  4. prije 11 sati

    Check out my recent article in Pharmaceutical Technology on the potential impact of in 2020.

  5. "Drug Quality: FDA officials discuss perceptions" via

  6. prije 12 sati

    Vuoi iscriverti alla newsletter di per per ricevere ogni mese i contenuti pubblicati sul blog? Clicca su questo link e compila il form:

  7. New at CADTH: updated review process, economic methods, and submission requirements >>

  8. HAS presents its action plan for the evaluation of innovative medicines >>

  9. prije 13 sati
  10. How complete is your lives & affiliations with data for , & employers? Learn more.

  11. prije 14 sati

    In her new article for , Decideum Consultant Claudia Forsyth provides insight into the future of innovative medicines in the NHS. Read on:

  12. Check out the latest jobs offerings for , and professionals on 's jobs portal! >>>

  13. Enable affiliates to focus on impactful local activities by auto-populating up to 80% of their draft submissions >>

  14. Check out my latest article: End-to-end China Market Entry Lifecycle Management It also includes my China market entry algorithm offering a top-down view of the major checkpoints in China market entry via

  15. prije 16 sati

    Nuestra Revista #163 de Enero-Febrero ya se encuentra disponible, abordando de forma especial los y el . Léela aquí:

  16. "Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix" via

  17. How new provides an improved framework for real-time decision-making in >>

  18. prije 17 sati
  19. 5. velj

    announces its comprehensive US / Technical Competence Center is soon to be commenced in the Bay Area, California. Read at

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.